Cargando…
1006. Do Antibiotic Choices Made in the ED Influence Inpatient Therapy?
BACKGROUND: Inappropriate antibiotic use (AU) is common among inpatients and may begin in the emergency department (ED). ED clinicians often make the first antibiotic decisions in patient care, but it is unknown whether or not these decisions influence inpatient AU. Understanding prescribing practic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811290/ http://dx.doi.org/10.1093/ofid/ofz360.870 |
_version_ | 1783462446316388352 |
---|---|
author | Jones, Travis M Dodds Ashley, Elizabeth Johnson, Melissa D Moehring, Rebekah W Sarubbi, Christina Wrenn, Rebekah |
author_facet | Jones, Travis M Dodds Ashley, Elizabeth Johnson, Melissa D Moehring, Rebekah W Sarubbi, Christina Wrenn, Rebekah |
author_sort | Jones, Travis M |
collection | PubMed |
description | BACKGROUND: Inappropriate antibiotic use (AU) is common among inpatients and may begin in the emergency department (ED). ED clinicians often make the first antibiotic decisions in patient care, but it is unknown whether or not these decisions influence inpatient AU. Understanding prescribing practices at transitions of care is critical for implementing effective stewardship initiatives. METHODS: We performed a retrospective cohort study of AU in patients admitted to Duke University Hospital through the ED between July and December 2018. Included encounters had a minimum 2-day length of stay and received an antibiotic in both the ED and inpatient setting. Individual encounter IDs were used to link ED and inpatient AU reports generated from the DASON Antimicrobial Stewardship Assessment Portal. We compared the last ED administration date/time to the first inpatient unit administration for each agent. An antibiotic started in the ED was considered continued upon admission if the first inpatient administration occurred within 30 hours following the last ED administration. Demographic, clinical indication on order entry, length of therapy, and prescriber data were also collected. RESULTS: We included 3,336 encounters and 2,940 unique patients in the analysis. The median (IQR) patient age was 60 (42–72) years, and the most common indications for AU in the ED were sepsis (23.1%), pneumonia (17.8%), ABSSSI (15.5%), and intra-abdominal infection (12.8%). At least one antibiotic initiated in the ED was continued upon admission within 30 hours in 2,495 (74.8%) encounters. The most common antibiotics continued upon admission were piperacillin/tazobactam (32.8%), vancomycin (24.9%), and ceftriaxone (13.7%). The most common indications for agents continued upon admission were pneumonia (18%), intra-abdominal infection (15%), and ABSSSI (15%). Two or more antibiotics were continued upon admission in 916 (27.4%) encounters. CONCLUSION: In our retrospective review of ED antibiotic encounters resulting in admission for at least 2 days, three out of four encounters had at least one antibiotic continued upon admission. This finding highlights the importance of initial appropriate antibiotic selection and suggests stewardship interventions should target EDs as well as inpatient prescribing. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6811290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68112902019-10-29 1006. Do Antibiotic Choices Made in the ED Influence Inpatient Therapy? Jones, Travis M Dodds Ashley, Elizabeth Johnson, Melissa D Moehring, Rebekah W Sarubbi, Christina Wrenn, Rebekah Open Forum Infect Dis Abstracts BACKGROUND: Inappropriate antibiotic use (AU) is common among inpatients and may begin in the emergency department (ED). ED clinicians often make the first antibiotic decisions in patient care, but it is unknown whether or not these decisions influence inpatient AU. Understanding prescribing practices at transitions of care is critical for implementing effective stewardship initiatives. METHODS: We performed a retrospective cohort study of AU in patients admitted to Duke University Hospital through the ED between July and December 2018. Included encounters had a minimum 2-day length of stay and received an antibiotic in both the ED and inpatient setting. Individual encounter IDs were used to link ED and inpatient AU reports generated from the DASON Antimicrobial Stewardship Assessment Portal. We compared the last ED administration date/time to the first inpatient unit administration for each agent. An antibiotic started in the ED was considered continued upon admission if the first inpatient administration occurred within 30 hours following the last ED administration. Demographic, clinical indication on order entry, length of therapy, and prescriber data were also collected. RESULTS: We included 3,336 encounters and 2,940 unique patients in the analysis. The median (IQR) patient age was 60 (42–72) years, and the most common indications for AU in the ED were sepsis (23.1%), pneumonia (17.8%), ABSSSI (15.5%), and intra-abdominal infection (12.8%). At least one antibiotic initiated in the ED was continued upon admission within 30 hours in 2,495 (74.8%) encounters. The most common antibiotics continued upon admission were piperacillin/tazobactam (32.8%), vancomycin (24.9%), and ceftriaxone (13.7%). The most common indications for agents continued upon admission were pneumonia (18%), intra-abdominal infection (15%), and ABSSSI (15%). Two or more antibiotics were continued upon admission in 916 (27.4%) encounters. CONCLUSION: In our retrospective review of ED antibiotic encounters resulting in admission for at least 2 days, three out of four encounters had at least one antibiotic continued upon admission. This finding highlights the importance of initial appropriate antibiotic selection and suggests stewardship interventions should target EDs as well as inpatient prescribing. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6811290/ http://dx.doi.org/10.1093/ofid/ofz360.870 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Jones, Travis M Dodds Ashley, Elizabeth Johnson, Melissa D Moehring, Rebekah W Sarubbi, Christina Wrenn, Rebekah 1006. Do Antibiotic Choices Made in the ED Influence Inpatient Therapy? |
title | 1006. Do Antibiotic Choices Made in the ED Influence Inpatient Therapy? |
title_full | 1006. Do Antibiotic Choices Made in the ED Influence Inpatient Therapy? |
title_fullStr | 1006. Do Antibiotic Choices Made in the ED Influence Inpatient Therapy? |
title_full_unstemmed | 1006. Do Antibiotic Choices Made in the ED Influence Inpatient Therapy? |
title_short | 1006. Do Antibiotic Choices Made in the ED Influence Inpatient Therapy? |
title_sort | 1006. do antibiotic choices made in the ed influence inpatient therapy? |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811290/ http://dx.doi.org/10.1093/ofid/ofz360.870 |
work_keys_str_mv | AT jonestravism 1006doantibioticchoicesmadeintheedinfluenceinpatienttherapy AT doddsashleyelizabeth 1006doantibioticchoicesmadeintheedinfluenceinpatienttherapy AT johnsonmelissad 1006doantibioticchoicesmadeintheedinfluenceinpatienttherapy AT moehringrebekahw 1006doantibioticchoicesmadeintheedinfluenceinpatienttherapy AT sarubbichristina 1006doantibioticchoicesmadeintheedinfluenceinpatienttherapy AT wrennrebekah 1006doantibioticchoicesmadeintheedinfluenceinpatienttherapy |